Flavian D. Brown

5.5k total citations · 2 hit papers
9 papers, 2.0k citations indexed

About

Flavian D. Brown is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Flavian D. Brown has authored 9 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Flavian D. Brown's work include Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (6 papers) and T-cell and B-cell Immunology (5 papers). Flavian D. Brown is often cited by papers focused on Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (6 papers) and T-cell and B-cell Immunology (5 papers). Flavian D. Brown collaborates with scholars based in United States, France and Switzerland. Flavian D. Brown's co-authors include W. Nicholas Haining, Martin W. LaFleur, Kathleen B. Yates, R. Anthony Barnitz, Shannon J. Turley, Arlene H. Sharpe, Sarah A. Weiss, John G. Doench, Kevin Bi and Diana Miao and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Flavian D. Brown

7 papers receiving 2.0k citations

Hit Papers

In vivo CRISPR screening identifies Ptpn2 as a cancer imm... 2016 2026 2019 2022 2017 2016 250 500 750

Peers

Flavian D. Brown
Jai Rautela Australia
Lynne Collins United States
Nikolina Bąbała Netherlands
Natalie B. Collins United States
Andrew J. Rech United States
Inja Waldhauer Switzerland
Kyle K. Payne United States
Robert T. Manguso United States
Jai Rautela Australia
Flavian D. Brown
Citations per year, relative to Flavian D. Brown Flavian D. Brown (= 1×) peers Jai Rautela

Countries citing papers authored by Flavian D. Brown

Since Specialization
Citations

This map shows the geographic impact of Flavian D. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavian D. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavian D. Brown more than expected).

Fields of papers citing papers by Flavian D. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavian D. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavian D. Brown. The network helps show where Flavian D. Brown may publish in the future.

Co-authorship network of co-authors of Flavian D. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Flavian D. Brown. A scholar is included among the top collaborators of Flavian D. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavian D. Brown. Flavian D. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Scanlon, Elizabeth, Flavian D. Brown, Andy Tu, et al.. (2022). 1332 Anti-CD161 antibody IMT-009 is a novel immunotherapeutic agent that reinvigorates T and NK cell function and anti-tumor efficacy through blocking interaction of CD161 with its ligand CLEC2D. Regular and Young Investigator Award Abstracts. A1383–A1383. 1 indexed citations
3.
Brown, Flavian D., Debattama R. Sen, Martin W. LaFleur, et al.. (2019). Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling. Nature Immunology. 20(12). 1668–1680. 55 indexed citations
4.
LaFleur, Martin W., Thao H. Nguyen, Kathleen B. Yates, et al.. (2019). A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nature Communications. 10(1). 1668–1668. 80 indexed citations
5.
Manguso, Robert T., Hans W. Pope, Margaret D. Zimmer, et al.. (2017). In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 547(7664). 413–418. 774 indexed citations breakdown →
6.
Sen, Debattama R., James J. Kaminski, R. Anthony Barnitz, et al.. (2016). The epigenetic landscape of T cell exhaustion. Science. 354(6316). 1165–1169. 659 indexed citations breakdown →
7.
Kim, Hye‐Jung, R. Anthony Barnitz, Taras Kreslavsky, et al.. (2015). Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science. 350(6258). 334–339. 297 indexed citations
8.
Brown, Flavian D. & Shannon J. Turley. (2015). Fibroblastic Reticular Cells: Organization and Regulation of the T Lymphocyte Life Cycle. The Journal of Immunology. 194(4). 1389–1394. 97 indexed citations
9.
Fletcher, Anne, Jessica S. Elman, Jillian L. Astarita, et al.. (2014). Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis. Science Translational Medicine. 6(249). 249ra109–249ra109. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026